ALUMIS INC. (ALMS)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $1M
- Sep 8 · No plan
- Form 4 sales
- 8
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJul 6 2026
Sold 5,000 shares at $28.00 ($140k)
Pangali Sanam, Chief Legal Officer
No 10b5-1 planSold 31% of holdings ($451k position)11,111 shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planAug 3 +28 days
Sold 2,692 shares at $26.37 ($71k)
Hardiman Roy C., Chief Business & Strategy Ofcr
No 10b5-1 planSold 1.3% of holdings ($5.5M position)207,746 shares leftFirst sale on recordFiling
- 3 Form 4 saleNo planAug 3 same day
Sold 3,282 shares at $26.37 ($87k)
Schroer John R., Chief Financial Officer
No 10b5-1 planSold 11.7% of holdings ($738k position)24,718 shares leftFirst sale on recordFiling
- 4 Form 4 saleNo planAug 3 same day
Sold 2,596 shares at $26.37 ($68k)
Goldstein David M, Chief Scientific Officer
No 10b5-1 planSold 7.7% of holdings ($885k position)30,970 shares leftFirst sale on recordFiling
- 5 Form 4 saleNo planAug 3 same day
Sold 2,447 shares at $26.37 ($65k)
Drappa Jorn, Chief Medical Officer
No 10b5-1 planSold 4.1% of holdings ($1.6M position)56,892 shares leftFirst sale on recordFiling
- 6 Form 4 saleNo planAug 3 same day
Sold 2,572 shares at $26.37 ($68k)
Bradley Mark Christopher, Chief Development Officer
No 10b5-1 planSold 5% of holdings ($1.3M position)48,533 shares leftFirst sale on recordFiling
- 7 Form 4 saleNo planAug 3 same day
Sold 1,364 shares at $26.37 ($36k)
Pangali Sanam, Chief Legal Officer
No 10b5-1 planSold 12.3% of holdings ($293k position)9,747 shares leftFiling
- 8 Form 4 saleNo planSep 8 +36 days
Sold 96,131 shares at $10.55 ($1M)
Akkaraju Srinivas, Director
No 10b5-1 planSold 4.5% of holdings ($22.4M position)2M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (8)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Akkaraju Srinivas | Director | Form 4 sale | 96,131 | $1M | 4.5% | No plan | SEC |
| Aug 3, 2026 | Pangali Sanam | Chief Legal Officer | Form 4 sale | 1,364 | $36k | 12.3% | No plan | SEC |
| Aug 3, 2026 | Bradley Mark Christopher | Chief Development Officer | Form 4 sale | 2,572 | $68k | 5.0% | No plan | SEC |
| Aug 3, 2026 | Drappa Jorn | Chief Medical Officer | Form 4 sale | 2,447 | $65k | 4.1% | No plan | SEC |
| Aug 3, 2026 | Goldstein David M | Chief Scientific Officer | Form 4 sale | 2,596 | $68k | 7.7% | No plan | SEC |
| Aug 3, 2026 | Schroer John R. | Chief Financial Officer | Form 4 sale | 3,282 | $87k | 11.7% | No plan | SEC |
| Aug 3, 2026 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Form 4 sale | 2,692 | $71k | 1.3% | No plan | SEC |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | Form 4 sale | 5,000 | $140k | 31.0% | Unusual | SEC |